Fixed dose drug combinations - are they pharmacoeconomically sound? Findings and implications especially for lower and middle income countries

Brian Godman, Holly McCabe, Trudy Leong, Debjani Mueller, Antony P Martin, Iris Hoxha, Julius C Mwita, Godfrey Mutashambara Rwegerera, Amos Massele, Juliana de Oliveira Costa, Renata Cristina Rezende Macedo do Nascimento, Livia Lovato Pires de Lemos, Konstantin Tachkov, Petya Milushewa, Okwen Patrick, Loveline Lum Niba, Ott Laius, Israel Sefah, Suhaj Abdulsalim, Fatemeh SoleymaniAnastasia N Guantai, Loice Achieng, Margaret Oluka, Arianit Jakupi, Konstantīns Logviss, Mohamed Azmi Hassali, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Olayinka O. Ogunleye, Zikria Saleem, Shazhad Hussain, Tomasz Bochenek, Ileana Mardare, Vanda Markovic-Pekovic, Alian A. Alrasheedy, Jurij Fürst, Dominik Tomek, Enos M Rampamba, Abubakr Alfadl, Adefolarin A Amu, Zinhle Matsebula, Thuy Nguyen Thi Phuong, Binh Nguyen Thanh, Aubrey Kalungia, Trust Zaranyika, Nyasha Masuka, Ioana D Olaru, Janney Wale, Ruaraidh Hill, Amanj Kurdi, Angela Timoney, Stephen Campbell, Johanna C MeyerShow 35 moreShow less